Related Experiment Video
Updated: Sep 27, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Limitations of maintenance therapy for viral respiratory infection-induced asthma
1Cystic Fibrosis/Respiratory Unit, Department of Child Health, University Hospital of Wales, Cardiff, Wales. doullij@:cf.ac.uk
Insights
Maintenance therapy for persistent asthma in children, particularly inhaled corticosteroids, significantly reduces exacerbations and healthcare visits. This treatment is not effective for children with intermittent wheezing due to viral infections without persistent symptoms.
Area of Science:
- Pediatric Pulmonology
- Allergy and Immunology
- Pharmacotherapy
Background:
- Asthma exacerbations pose significant risks to children's health and well-being.
- Effective maintenance therapies are crucial for managing persistent childhood asthma.
- Identifying appropriate treatment strategies for different asthma phenotypes is essential.
Purpose of the Study:
- To evaluate the effectiveness of maintenance therapies in reducing asthma exacerbations in children.
- To compare the benefits of nedocromil sodium, inhaled corticosteroids, and montelukast.
- To determine the impact of these therapies on healthcare utilization and oral corticosteroid rescue needs.
Main Methods:
- Retrospective analysis of treatment outcomes in asthmatic children.
- Comparison of exacerbation rates across different maintenance therapy groups.
- Assessment of healthcare visits and oral corticosteroid use.
Main Results:
- Maintenance therapy with nedocromil sodium, inhaled corticosteroids, or montelukast decreased asthma exacerbations in children with persistent symptoms.
- Inhaled corticosteroids provided the greatest benefit, reducing exacerbations, oral corticosteroid needs, urgent visits, and hospitalizations by approximately 50% in preschool- and school-aged children.
- Maintenance therapy showed no benefit in children with intermittent virus-induced wheezing without persistent symptoms.
Conclusions:
- Regular inhaled corticosteroids are highly effective for managing persistent asthma in children.
- Nedocromil sodium and montelukast also offer benefits for persistent asthma.
- Maintenance therapy is not indicated for children with intermittent viral wheezing and no persistent symptoms.
Abstract:
In asthmatic children with persistent symptoms, maintenance therapy with nedocromil sodium, inhaled corticosteroids, or montelukast is associated with a decreased rate of asthma exacerbations. The greatest benefit is seen with use of regular inhaled corticosteroids in preschool- or school-age children, in whom asthma exacerbations, the need for rescue oral corticosteroids, unscheduled urgent medical visits, and hospitalizations are all decreased by approximately 50%. However, maintenance therapy is not beneficial in children with intermittent respiratory virus-induced wheezing without persistent symptoms.
Related Concept Videos
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Asthma-IV: Nursing Management
First, in...
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Asthma-III: Symptoms and Complications
Classification of Asthma
Asthma I: Introduction